Technology News and Research

RSS

Signum Biosciences awarded $1.6 million SBIR Phase II grant

Signum Biosciences, Inc has been awarded a $1.6 million Small Business Innovation Research (SBIR) Phase II grant by the National Institute of Allergy and Infection Diseases (NIAID) to continue the development of its topical STM (Signal Transduction Modulator) anti-inflammatory technology for the treatment of inflammatory skin disease.

11 Sep 2009

FDA accepts Merz Pharmaceuticals' premarket approval application for Belotero Balance

Merz Pharmaceuticals, LLC, a leading specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review Merz's premarket approval (PMA) application for Belotero(R) Balance.

11 Sep 2009

Bioneutral's broad spectrum antimicrobial eradicates the H1N1 swine flu virus

BioNeutral Group, Inc. (“BioNeutral”) (OTCBB:BONU), a specialty chemical technology based Life Science Company, announced today that independent lab test results conducted at Microbiotest Inc. of Sterling, Virginia, demonstrated that Ygiene® antimicrobial diluted 1 to 10 with water can totally eradicated the H1N1 Swine Flu virus in 59 seconds on an unclean, soiled surface.

11 Sep 2009

Dell enters health IT fray, catering to small providers

The computer company Dell unveiled a new offering to doctors and hospitals shopping for an electronic medical records system Thursday, Dow Jones Newswires reports. Dell's system will be cheaper, easier and more compatible with other products, the company said, helping to overcome longstanding health information technology obstacles (Solsman, 9/10).

11 Sep 2009

Oculus Innovative Sciences Receives Medicare HCPCS Code For Reimbursement Of Microcyn® Skin & Wound Hydrogel

Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, announced today that Noridian Administrative Services LLC, which is the pricing, data analysis and coding contractor for the Medicare program with respect to durable medical equipment, prosthetics, orthotics, and medical supplies, has assigned a Medicare HCPCS code for Oculus’ recently introduced Microcyn Skin & Wound HydroGel.

11 Sep 2009

2nd West Coast Forum: An opportunity to gather the latest information on clinical supply chain management

The Center for Business Intelligence (CBI) is pleased to announce the full agenda for their 2nd West Coast Forum on Clinical Supply Chain Management. The conference takes place in Burlingame, CA, on October 28-29, 2009.

11 Sep 2009

Immigration and education policies to impact United states' leadership in science and discovery

Immigration and education policy experts gathered on Capitol Hill today to address the impact of policies related to U.S. medical innovation. The briefing, titled Education & Immigration: The Building Blocks of Innovation, was sponsored by the Council for American Medical Innovation as the first in a three-part series, Recovery Through Discovery, which examines medical innovation as a driver of U.S. economic recovery and enhanced global leadership in science.

11 Sep 2009

Stem Cell Therapy International to merge with Histostem Korea

Stem Cell Therapy International Inc. (OTCBB: SCII) announced today that the Company has agreed to be a party to the settlement between Histostem, Incorporated, a Delaware Corporation ("Histostem USA") and Histostem Corporation, a Korean Corporation ("Histostem Korea"). The agreement is contingent upon the close of the SCII and Histostem Korea merger, and specifically, the agreement is contingent that at the close of the merger, SCII will acquire no less than 90% of the total fully diluted equity of Histostem Korea.

11 Sep 2009

Results from a preclinical study of Variation's influenza vaccine to be presented at ICAAC meeting

Variation Biotechnologies, Inc. (VBI), an emerging leader in the discovery and development of novel vaccines to fight infectious diseases, today announced that it plans to present positive results from a preclinical study of the company’s proprietary influenza vaccine at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), being held at the Moscone Convention Center in San Francisco, California.

11 Sep 2009

Elderberry extract prevents H1N1 infection in vitro

A recent research study has given new scientific evidence to the long-held empirical belief that elderberries possess antiviral activities. The research involved a specific, reproducible elderberry extract developed by HerbalScience Group LLC, and succeeded in identifying key chemical components of the extract that inhibited in vitro infection and were shown to bind directly to Human Influenza A (H1N1) virus particles. The binding blocked the ability of the viruses to enter host cells, and thereby effectively preventing H1N1 infection in vitro.

11 Sep 2009

USPTO allows Isis an additional patent for single-stranded RNAi technology

Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today that the United States Patent and Trademark Office (USPTO) has allowed an Isis patent application that further expands the scope of the "Crooke" patent estate. The newly allowed patent broadly covers methods of cleaving a target RNA via a double-stranded ribonuclease mechanism, including the RNAi mechanism, with chemically modified, single-stranded RNA-containing drugs.

11 Sep 2009

Pergamum to develop Karolinska dermatology and wound healing companies

Pergamum AB has announced its formation; Pergamum will commercialize the Karolinska Development dermatology and wound healing interests, and create a broad-based therapeutic company in its focus areas.

11 Sep 2009

VHGI to distribute Secure Document Courier and Storage technology

VirtualHealth Technologies, Inc. (OTC Bulletin Board: VHGI), a provider of secure technology for electronic health records and connectivity for web-based healthcare solutions, announced today an agreement with its subsidiary Secure eHealth to market DRM Security's Secure Document Courier and Storage technology (Cifra(TM)) to the healthcare markets.

11 Sep 2009

USPTO recognizes RZN Nutraceuticals' HerbaZorb as a patentable delivery system

RZN Nutraceuticals, Inc.,(www.rznnutra.com) a leading developer of proven effective herbal products which have been clinically tested on sufferers of severe arthritis and migraines has announced receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for the firm's absorption and delivery system process methodology patent application, a technology RZN has named HerbaZorb(TM).

11 Sep 2009

Delcath Systems to continue Phase III clinical trial

Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the Data and Safety Monitoring Board ("DSMB") reviewed clinical data on 77 patients enrolled in its pivotal Phase III clinical trial and unanimously recommended that the trial continue to enroll patients with the goal of reaching the 92 patients required to complete the study.

11 Sep 2009

Hospital of Saint Raphael implements Think First’s Instant Informatics revenue cycle tool

Think First announced today that the Hospital of Saint Raphael’s Faculty Practice Plan (New Haven, CT) has implemented Think First’s Instant Informatics, a robust, best-practice revenue cycle tool that enables physician practices to measure, transform, and sustain organizational performance, drive up physician practice revenue, and achieve operational improvements.

11 Sep 2009

PPJ Enterprise focuses on business development of the medical billing firm PBS

PPJ Enterprise (PPJ) (PINKSHEETS: PPJE), a leader in proprietary automated healthcare multi-specialty provider reimbursement cycle technology and EHR development/information management digital system software for health care providers. PPJ Enterprises has focused all of its resources currently on the strategic business development of the medical billing firm PBS.

11 Sep 2009

University of Pittsburgh invites media to participate in the eds-meds tour program

Media are invited to participate in the science and technology tours being held in conjunction with the Pittsburgh G-20 Summit Sept. 24-25. Twelve one-hour tours—hosted by the University of Pittsburgh, Carnegie Mellon University, and the University of Pittsburgh Medical Center—are being offered on Monday, Sept. 21. They will highlight the science and technology that is driving the region’s economy.

11 Sep 2009

Kaiser Permanente hosts in-person and virtual Residency Program Open House

In September, medical students begin searching for residency training programs. In today's economy, especially with college loans entering repayment, medical students have fewer dollars available to visit multiple residency programs. Kaiser Permanente, a leader in graduate medical education and technology, is responding to this need by hosting both an in-person and virtual Residency Program Open House.

11 Sep 2009

Solos obtains purchase order for surgical endoscopy instruments

Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company has received a purchase order for the MammoView(TM) line of surgical endoscopy instruments from the University of Missouri Health System, which boasts one of the most comprehensive health-care networks in Missouri.

11 Sep 2009

Technology News and Research

Signum Biosciences awarded $1.6 million SBIR Phase II grant

FDA accepts Merz Pharmaceuticals' premarket approval application for Belotero Balance

Bioneutral's broad spectrum antimicrobial eradicates the H1N1 swine flu virus

Dell enters health IT fray, catering to small providers

Oculus Innovative Sciences Receives Medicare HCPCS Code For Reimbursement Of Microcyn® Skin & Wound Hydrogel

2nd West Coast Forum: An opportunity to gather the latest information on clinical supply chain management

Immigration and education policies to impact United states' leadership in science and discovery

Stem Cell Therapy International to merge with Histostem Korea

Results from a preclinical study of Variation's influenza vaccine to be presented at ICAAC meeting

Elderberry extract prevents H1N1 infection in vitro

USPTO allows Isis an additional patent for single-stranded RNAi technology

Pergamum to develop Karolinska dermatology and wound healing companies

VHGI to distribute Secure Document Courier and Storage technology

USPTO recognizes RZN Nutraceuticals' HerbaZorb as a patentable delivery system

Delcath Systems to continue Phase III clinical trial

Hospital of Saint Raphael implements Think First’s Instant Informatics revenue cycle tool

PPJ Enterprise focuses on business development of the medical billing firm PBS

University of Pittsburgh invites media to participate in the eds-meds tour program

Kaiser Permanente hosts in-person and virtual Residency Program Open House

Solos obtains purchase order for surgical endoscopy instruments

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News